These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9609128)

  • 41. Overexpression of the glycogen targeting (G(M)) subunit of protein phosphatase-1.
    Yamamoto-Honda R; Honda Z; Kaburagi Y; Ueki K; Kimura S; Akanuma Y; Kadowaki T
    Biochem Biophys Res Commun; 2000 Sep; 275(3):859-64. PubMed ID: 10973812
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibition of the interaction between protein phosphatase 1 glycogen-targeting subunit and glycogen phosphorylase increases glycogen synthesis in primary rat hepatocytes.
    Zibrova D; Grempler R; Streicher R; Kauschke SG
    Biochem J; 2008 Jun; 412(2):359-66. PubMed ID: 18298402
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pioglitazone ameliorates high glucose induced desensitization of insulin receptor kinase in Rat 1 fibroblasts in culture.
    Maegawa H; Tachikawa-Ide R; Ugi S; Iwanishi M; Egawa K; Kikkawa R; Shigeta Y; Kashiwagi A
    Biochem Biophys Res Commun; 1993 Dec; 197(3):1078-82. PubMed ID: 8280122
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pioglitazone hydrochloride inhibits cholesterol absorption and lowers plasma cholesterol concentrations in cholesterol-fed rats.
    Colca JR; Dailey CF; Palazuk BJ; Hillman RM; Dinh DM; Melchior GW; Spilman CH
    Diabetes; 1991 Dec; 40(12):1669-74. PubMed ID: 1756906
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antidiabetic effects of total flavonoids from Litsea Coreana leve on fat-fed, streptozotocin-induced type 2 diabetic rats.
    Lu YX; Zhang Q; Li J; Sun YX; Wang LY; Cheng WM; Hu XY
    Am J Chin Med; 2010; 38(4):713-25. PubMed ID: 20626057
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Disparate effects of antidiabetic drugs on arterial contraction.
    Peuler JD; Miller JA; Bourghli M; Zammam HY; Soltis EE; Sowers JR
    Metabolism; 1997 Oct; 46(10):1199-205. PubMed ID: 9322807
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Studies on the effects of insulin and acetylcholine on activation of glycogen synthase and on glycogenesis in hepatocytes.
    Akpan JO; Gardner R; Wagle SR
    Biochem Biophys Res Commun; 1974 Nov; 61(1):222-9. PubMed ID: 4216349
    [No Abstract]   [Full Text] [Related]  

  • 48. Mechanism of activation of liver glycogen synthase by swelling.
    Meijer AJ; Baquet A; Gustafson L; van Woerkom GM; Hue L
    J Biol Chem; 1992 Mar; 267(9):5823-8. PubMed ID: 1348248
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Studies on antidiabetic agents. X. Synthesis and biological activities of pioglitazone and related compounds.
    Momose Y; Meguro K; Ikeda H; Hatanaka C; Oi S; Sohda T
    Chem Pharm Bull (Tokyo); 1991 Jun; 39(6):1440-5. PubMed ID: 1934164
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Insulin receptors and functions in normal and spontaneously transformed cloned rat hepatocytes.
    Petersen B; Blecher M
    Exp Cell Res; 1979 Apr; 120(1):119-25. PubMed ID: 108115
    [No Abstract]   [Full Text] [Related]  

  • 51. Stimulation of FA and phosphatase-1 activities by insulin in 3T3-L1 cells.
    Villa-Moruzzi E
    FEBS Lett; 1989 Dec; 258(2):208-10. PubMed ID: 2557236
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Diet and diabetic state modify glycogen synthase activity and expression in rat hepatocytes.
    Libal-Weksler Y; Gotlibovitz O; Stark AH; Madar Z
    J Nutr Biochem; 2001 Aug; 12(8):458-464. PubMed ID: 11834204
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impaired glycogen synthase activating system in human diabetic polymorphonuclear leukocytes.
    Goldstein DE; Curnow RT
    Diabetes; 1980 Mar; 29(3):217-20. PubMed ID: 6247232
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Insulin stimulation of glycogen synthase activity in cultured human fibroblasts from diabetic and control subjects.
    Craig JW; Huang LS; Larner J
    Diabetologia; 1980; 18(2):109-13. PubMed ID: 6767640
    [No Abstract]   [Full Text] [Related]  

  • 55. Inability of insulin to activate liver glycogen transferase D phosphatase in the diabetic pancreatectomized dog.
    Bishop JS
    Biochim Biophys Acta; 1970 May; 208(2):208-18. PubMed ID: 5420974
    [No Abstract]   [Full Text] [Related]  

  • 56. Living cells in action.
    SPEIDEL CC
    Sci Prog (New Haven); 1947; 5():280-314. PubMed ID: 20260193
    [No Abstract]   [Full Text] [Related]  

  • 57. Activation of G proteins by GIV-GEF is a pivot point for insulin resistance and sensitivity.
    Ma GS; Lopez-Sanchez I; Aznar N; Kalogriopoulos N; Pedram S; Midde K; Ciaraldi TP; Henry RR; Ghosh P
    Mol Biol Cell; 2015 Nov; 26(23):4209-23. PubMed ID: 26378251
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pioglitazone.
    Gillies PS; Dunn CJ
    Drugs; 2000 Aug; 60(2):333-43; discussion 344-5. PubMed ID: 10983737
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Insulin action on protein phosphatase-1 activation is enhanced by the antidiabetic agent pioglitazone in cultured diabetic hepatocytes.
    Pugazhenthi S; Khandelwal RL
    Mol Cell Biochem; 1998 May; 182(1-2):185-91. PubMed ID: 9609128
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An antidiabetic thiazolidinedione potentiates insulin stimulation of glycogen synthase in rat adipose tissues.
    Berger J; Biswas C; Hayes N; Ventre J; Wu M; Doebber TW
    Endocrinology; 1996 May; 137(5):1984-90. PubMed ID: 8612539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.